These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30989451)

  • 21. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-based capsaicin-loaded nano-colloidal biocompatible topical carriers with enhanced analgesic potential and decreased dermal irritation.
    Raza K; Shareef MA; Singal P; Sharma G; Negi P; Katare OP
    J Liposome Res; 2014 Dec; 24(4):290-6. PubMed ID: 24766639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanostructured lipid carriers of pioglitazone for transdermal application: from experimental design to bioactivity detail.
    Alam S; Aslam M; Khan A; Imam SS; Aqil M; Sultana Y; Ali A
    Drug Deliv; 2016; 23(2):601-9. PubMed ID: 24937378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of bioavailability through transdermal drug delivery of paliperidone palmitate-loaded nanostructured lipid carriers.
    Raval S; Jani P; Patil P; Thakkar P; Sawant K
    Ther Deliv; 2021 Aug; 12(8):583-596. PubMed ID: 34286598
    [No Abstract]   [Full Text] [Related]  

  • 26. Development and evaluation of ultra-small nanostructured lipid carriers: novel topical delivery system for athlete's foot.
    Singh S; Singh M; Tripathi CB; Arya M; Saraf SA
    Drug Deliv Transl Res; 2016 Feb; 6(1):38-47. PubMed ID: 26542152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations.
    Mahmood A; Rapalli VK; Gorantla S; Waghule T; Singhvi G
    Drug Deliv Transl Res; 2022 May; 12(5):1118-1135. PubMed ID: 33895936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne.
    Jain A; Garg NK; Jain A; Kesharwani P; Jain AK; Nirbhavane P; Tyagi RK
    Drug Dev Ind Pharm; 2016; 42(6):897-905. PubMed ID: 26577703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Pradhan M; Singh D; Murthy SN; Singh MR
    Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.
    Babaei S; Ghanbarzadeh S; Adib ZM; Kouhsoltani M; Davaran S; Hamishehkar H
    Pharmazie; 2016 May; 71(5):247-51. PubMed ID: 27348967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanostructured lipid carrier-embedded polyacrylic acid transdermal patches for improved transdermal delivery of capsaicin.
    Arunprasert K; Pornpitchanarong C; Piemvuthi C; Siraprapapornsakul S; Sripeangchan S; Lertsrimongkol O; Opanasopit P; Patrojanasophon P
    Eur J Pharm Sci; 2022 Jun; 173():106169. PubMed ID: 35318130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
    Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colloidal nanostructured lipid carriers of pentoxifylline produced by microwave irradiation ameliorates imiquimod-induced psoriasis in mice.
    Ghate VM; Kodoth AK; Shah A; Vishalakshi B; Lewis SA
    Colloids Surf B Biointerfaces; 2019 Sep; 181():389-399. PubMed ID: 31170645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.
    You P; Yuan R; Chen C
    Drug Des Devel Ther; 2017; 11():2743-2752. PubMed ID: 29075099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical delivery of dexamethasone acetate from hydrogel containing nanostructured liquid carriers and the drug.
    Tung NT; Huyen VT; Chi SC
    Arch Pharm Res; 2015 Nov; 38(11):1999-2007. PubMed ID: 25940221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
    Wang Y; Wang S; Shi P
    Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-based nanoformulation optimization for achieving cutaneous targeting: Niosomes as the potential candidates to fulfill this aim.
    Lin YK; Hsiao CY; Alshetaili A; Aljuffali IA; Chen EL; Fang JY
    Eur J Pharm Sci; 2023 Jul; 186():106458. PubMed ID: 37137418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.